Early discharge after paediatric liver biopsy: A prospective observational study

Fie Brantbjerg Tinning1, Jakob Stensballe2, Birthe Henriksen3

  • 1Department of Paediatric and Adolescent Medicine, Rigshospitalet, Copenhagen, Denmark.

Insights

Early discharge after percutaneous liver biopsy (PLB) is safe for low-risk pediatric patients. Risk stratification effectively identifies patients eligible for reduced hospital stays, minimizing complications.

Area of Science:

  • Pediatric Gastroenterology
  • Interventional Radiology
  • Patient Safety

Background:

  • Percutaneous liver biopsy (PLB) is a common procedure in pediatric patients.
  • Historically, prolonged observation periods are standard after PLB.
  • Optimizing discharge protocols can improve patient flow and reduce healthcare costs.

Purpose of the Study:

  • To assess the safety and efficacy of early discharge after PLB in children.
  • To evaluate a risk stratification model for predicting bleeding complications.
  • To determine if low-risk pediatric patients can be safely discharged earlier post-PLB.

Main Methods:

  • Prospective observational cohort study design.
  • Paediatric patients undergoing PLB were stratified into low- and high-risk groups based on bleeding history and labs.
  • Low-risk group discharged after 6 hours; high-risk group observed for 24 hours.

Main Results:

  • 167 patients included: 119 (71%) low-risk, 48 (29%) high-risk.
  • Two minor bleeding events occurred, both in the high-risk group.
  • No bleeding complications were observed in the early-discharge (low-risk) group.

Conclusions:

  • Pre-procedural risk stratification is effective in identifying bleeding risk in pediatric patients.
  • Early discharge after PLB is safe for carefully selected low-risk children.
  • This strategy can significantly reduce hospital admission duration for eligible pediatric patients.
Abstract